Promotion of allergic immune responses by intranasally-administrated nanosilica particles in mice
Open Access
- 4 March 2011
- journal article
- Published by Springer Science and Business Media LLC in Nanoscale Research Letters
- Vol. 6 (1), 195
- https://doi.org/10.1186/1556-276x-6-195
Abstract
With the increase in use of nanomaterials, there is growing concern regarding their potential health risks. However, few studies have assessed the role of the different physical characteristics of nanomaterials in allergic responses. Here, we examined whether intranasally administered silica particles of various sizes have the capacity to promote allergic immune responses in mice. We used nanosilica particles with diameters of 30 or 70 nm (nSP30 or nSP70, respectively), and conventional micro-sized silica particles with diameters of 300 or 1000 nm (nSP300 or mSP1000, respectively). Mice were intranasally exposed to ovalbumin (OVA) plus each silica particle, and the levels of OVA-specific antibodies (Abs) in the plasma were determined. Intranasal exposure to OVA plus smaller nanosilica particles tended to induce a higher level of OVA-specific immunoglobulin (Ig) E, IgG and IgG1 Abs than did exposure to OVA plus larger silica particles. Splenocytes from mice exposed to OVA plus nSP30 secreted higher levels of Th2-type cytokines than mice exposed to OVA alone. Taken together, these results indicate that nanosilica particles can induce allergen-specific Th2-type allergic immune responses in vivo. This study provides the foundations for the establishment of safe and effective forms of nanosilica particles.Keywords
This publication has 21 references indexed in Scilit:
- The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1β production, ROS production and endosomal ruptureBiomaterials, 2010
- Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applicationsAdvanced Drug Delivery Reviews, 2010
- Titanium dioxide induces different levels of IL-1β production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin BBiochemical and Biophysical Research Communications, 2010
- In Vivo Study of Biodistribution and Urinary Excretion of Surface-Modified Silica NanoparticlesAnalytical Chemistry, 2008
- Nanosilica—from medicine to pest controlZeitschrift für Parasitenkunde, 2008
- Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes2007
- Toxic Potential of Materials at the NanolevelScience, 2006
- Nanomedicine and nanotoxicology: two sides of the same coinNanomedicine: Nanotechnology, Biology and Medicine, 2005
- Organically modified silica nanoparticles: A nonviral vector for in vivo gene delivery and expression in the brainProceedings of the National Academy of Sciences of the United States of America, 2005
- Inflammatory Time Course after Quartz InstillationAmerican Journal of Respiratory Cell and Molecular Biology, 2004